Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The purpose of this study is to compare the outcomes of patients with chronic kidney disease (CKD) randomly assigned to 2 treatment groups, which differ only in their targeted hemoglobin levels. This study will test the primary hypothesis that the level of anemia correction with once weekly dosing of PROCRIT® (Epoetin alfa) in patients with chronic kidney disease will decrease mortality and cardiovascular morbidity.
Epistemonikos ID: 382a11680e186d5d042f149ab08d88f7f758dd4d
First added on: May 04, 2024